Minireviews
Copyright ©The Author(s) 2015.
World J Hepatol. May 18, 2015; 7(8): 1133-1141
Published online May 18, 2015. doi: 10.4254/wjh.v7.i8.1133
Figure 1
Figure 1 Sustained virological response rates for treatment-naïve patients with cirrhosis who were treated with peginterferon and ribavirin. 1Comparison between cirrhosis/bridging fibrosis vs others; 2Comparison between an Ishak fibrosis score of 6 vs scores of 0-5; 3Data from 3 studies including the study by Fried et al[6] listed above; 4Comparison between cirrhotic patients vs those without advanced fibrosis. White column: Non-cirrhosis (without advanced fibrosis); Black column: Cirrhosis (with advanced fibrosis). G: Genotype.